294 related articles for article (PubMed ID: 28347260)
1. A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.
Feng M; Sparkman NL; Sui N; Li M
J Psychopharmacol; 2017 Apr; 31(4):474-486. PubMed ID: 28347260
[TBL] [Abstract][Full Text] [Related]
2. Time-dependent sensitization of antipsychotic effect in adolescent male and female rats.
Ding X; Li X; Shu Q; Wu R; Hu G; Li M
Behav Brain Res; 2017 Jun; 328():186-194. PubMed ID: 28412306
[TBL] [Abstract][Full Text] [Related]
3. Drug-drug conditioning between citalopram and haloperidol or olanzapine in a conditioned avoidance response model: implications for polypharmacy in schizophrenia.
Sparkman NL; Li M
Behav Pharmacol; 2012 Oct; 23(7):658-68. PubMed ID: 22903071
[TBL] [Abstract][Full Text] [Related]
4. Does antagonism at 5-HT2A receptors potentiate Dâ‚‚ blockade-induced disruption of conditioned avoidance response?
Gao J; Huang Y; Li M
Exp Clin Psychopharmacol; 2019 Apr; 27(2):103-108. PubMed ID: 30556732
[TBL] [Abstract][Full Text] [Related]
5. Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.
Li M; Sun T; Zhang C; Hu G
Psychopharmacology (Berl); 2010 Sep; 212(1):45-57. PubMed ID: 20623111
[TBL] [Abstract][Full Text] [Related]
6. Nicotine-antipsychotic drug interactions and attentional performance in female rats.
Rezvani AH; Levin ED
Eur J Pharmacol; 2004 Feb; 486(2):175-82. PubMed ID: 14975706
[TBL] [Abstract][Full Text] [Related]
7. Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance.
Murphy CA; Feldon J
Behav Pharmacol; 2000 Jun; 11(3-4):307-16. PubMed ID: 11103885
[TBL] [Abstract][Full Text] [Related]
8. Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats.
Addy N; Levin ED
Neuropsychopharmacology; 2002 Oct; 27(4):534-41. PubMed ID: 12377390
[TBL] [Abstract][Full Text] [Related]
9. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
Chou S; Davis C; Jones S; Li M
Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
[TBL] [Abstract][Full Text] [Related]
10. Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.
Qin R; Chen Y; Li M
Neuropharmacology; 2013 Dec; 75():356-64. PubMed ID: 23954676
[TBL] [Abstract][Full Text] [Related]
11. Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: contrast with haloperidol and chlordiazepoxide.
Mead A; Li M; Kapur S
Pharmacol Biochem Behav; 2008 Oct; 90(4):551-62. PubMed ID: 18547622
[TBL] [Abstract][Full Text] [Related]
12. Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.
Qiao J; Zhang Q; Li M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():177-85. PubMed ID: 24140929
[TBL] [Abstract][Full Text] [Related]
13. An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).
Brown RW; Kirby SL; Denton AR; Dose JM; Cummins ED; Drew Gill W; Burgess KC
Schizophr Res; 2018 Apr; 194():107-114. PubMed ID: 28314679
[TBL] [Abstract][Full Text] [Related]
14. A comparison between a new antipsychotic screening technique (shelf jump avoidance) and a classical discriminative avoidance paradigm.
Herman RL; Malick JB; Kubena RK
Commun Psychopharmacol; 1979; 3(3):165-71. PubMed ID: 40728
[No Abstract] [Full Text] [Related]
15. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.
Blackburn JR; Phillips AG
Psychopharmacology (Berl); 1989; 98(4):453-9. PubMed ID: 2570431
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the motor initiation hypothesis of APD-induced conditioned avoidance decreases.
Li M; Parkes J; Fletcher PJ; Kapur S
Pharmacol Biochem Behav; 2004 Aug; 78(4):811-9. PubMed ID: 15301940
[TBL] [Abstract][Full Text] [Related]
17. Clozapine and the mitogen-activated protein kinase signal transduction pathway: implications for antipsychotic actions.
Browning JL; Patel T; Brandt PC; Young KA; Holcomb LA; Hicks PB
Biol Psychiatry; 2005 Mar; 57(6):617-23. PubMed ID: 15780848
[TBL] [Abstract][Full Text] [Related]
18. Stability of avoidance behaviour following repeated intermittent treatment with clozapine, olanzapine or D,L-govadine.
Ashby DM; Lapish CC; Phillips AG
Behav Pharmacol; 2015 Feb; 26(1-2):133-8. PubMed ID: 25325293
[TBL] [Abstract][Full Text] [Related]
19. A lever-release version of the conditioned avoidance response paradigm: effects of haloperidol, clozapine, sulpiride, and BMY-14802.
White IM; Ciancone MT; Haracz JL; Rebec GV
Pharmacol Biochem Behav; 1992 Jan; 41(1):29-35. PubMed ID: 1347175
[TBL] [Abstract][Full Text] [Related]
20. Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.
Li M; Sun T; Mead A
J Neural Transm (Vienna); 2012 Apr; 119(4):497-505. PubMed ID: 21986871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
